SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

INPUT OF A PATIENT ADVISORY GROUP INTO EVALUATING THE BENEFIT: RISK PROFILE OF EXISTING AND POTENTIAL COPD THERAPIES

Burrage, DR; Tumilty, M; Ruickbie, S; Baker, EH (2016) INPUT OF A PATIENT ADVISORY GROUP INTO EVALUATING THE BENEFIT: RISK PROFILE OF EXISTING AND POTENTIAL COPD THERAPIES. THORAX, 71 (Suppl 3). A206-A207. ISSN 0040-6376 https://doi.org/10.1136/thoraxjnl-2016-209333.365
SGUL Authors: Baker, Emma Harriet Burrage, Daniel Richard

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (359kB)
Item Type: Article
Additional Information: This article has been accepted for publication in Thorax following peer review. The definitive copyedited, typeset version Burrage D, Tumilty M, Ruickbie S, et al P222 Input of a patient advisory group into evaluating the benefit: risk profile of existing and potential copd therapies Thorax 2016;71:A206-A207. is available online at: http://dx.doi.org/10.1136/thoraxjnl-2016-209333.365
Keywords: Respiratory System, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: THORAX
ISSN: 0040-6376
Dates:
DateEvent
1 December 2016Published
15 November 2016Published Online
Publisher License: Publisher's own licence
Web of Science ID: WOS:000393131200359
URI: https://openaccess.sgul.ac.uk/id/eprint/108683
Publisher's version: https://doi.org/10.1136/thoraxjnl-2016-209333.365

Actions (login required)

Edit Item Edit Item